Veterans Health Library
FLIBANSERIN (fly BAN ser in) treats hypoactive sexual desire disorder (HSDD). It works by balancing substances in the brain that help regulate mood and increase sex drive. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. They need to know if you have any of these conditions: History of depression or other mental health conditions An unusual or allergic reaction to flibanserin, other medications, foods, dyes, or preservatives Take this medication by mouth with water. Take it as directed on the prescription label.
- Summary: A daily, non-hormonal pill for premenopausal women with HSDD.
- Key benefit: Modest increase in sexual desire and satisfying events for some.
- Key risk: Potentially severe interactions with alcohol and many medications.
- Management: Strict adherence to REMS, bedtime dosing, and no alcohol.
- Patient profile: Premenopausal woman with distress from low desire, otherwise healthy.
- Provider role: Certify, counsel, monitor, and manage expectations.
- Place in therapy: One option among a comprehensive approach to sexual health.
- Public health impact: Highlighted need for and challenges in female sexual medicine.
- Future: Continued evaluation of real-world outcomes and safety profile.
This medication should only be taken at bedtime. Do not take this medication with grapefruit juice. If you have 1 or 2 alcohol-containing drinks, wait at least 2 hours before taking this medication at bedtime. Do not take your bedtime dose if you have consumed 3 or more alcohol-containing drinks. After taking this medication at bedtime, do not drink alcohol until the next day. A special MedGuide will be given to you by the pharmacist with each prescription and refill.
Addyi is the #1 Prescribed Treatment for HSDD.1
Generalized HSDD refers to HSDD that occurs regardless of the type of stimulation, situation, or partner. ADDYI is not indicated to enhance sexual performance. Moderate or strong cytochrome P450 3A4 (CYP3A4) inhibitors Known hypersensitivity to ADDYI or any of its components. Reactions, including anaphylaxis, reactions consistent with angioedema, pruritus, and urticaria have been reported. Hypotension and Syncope Due to an Interaction with Alcohol: See Boxed Warning for risks associated with alcohol consumption.
Hazard Classifications
After taking ADDYI at bedtime, advise patients to not use alcohol until the following day. Hypotension and Syncope with CYP3A4 Inhibitors: See Boxed Warning and Contraindication about use with moderate or strong cytochrome P450 3A4. Concomitant use of multiple weak CYP3A4 inhibitors that may include herbal supplements (e.g., ginkgo, resveratrol) or non-prescription drugs (e.g., cimetidine) could also lead to clinically relevant increases in flibanserin concentrations that may increase the risk of hypotension and syncope. Central Nervous System (CNS) Depression (e.g., Somnolence, Sedation): Can occur with ADDYI alone and is exacerbated by other CNS depressants. The risk of CNS depression is also increased if ADDYI is taken during waking hours.
Advocacy groups
Patients should avoid activities requiring full alertness (e.g., operating machinery or driving) until at least six hours after each dose and until they know how ADDYI affects them. Hypotension and Syncope with ADDYI Alone: The use of ADDYI - without other concomitant medications known to cause hypotension or syncope - can cause hypotension and syncope. The risk is increased if ADDYI is taken during waking hours or if higher than the recommend dose is taken. Syncope and Hypotension in Patients with Hepatic Impairment: Any degree of hepatic impairment significantly increases flibanserin concentrations, which can lead to hypotension and syncope. ADDYI is contraindicated in patients with hepatic impairment. Be sure to read this information carefully each time.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 100mg | 180 + 8 Pills | 199.37€ 189.88€ | |
| Viagra Generic | 25mg | 90 + 6 Pills | 105.03€ 100.03€ | |
| Cialis Generic | 5mg | 360 + 10 Pills | 268.08€ 255.31€ | |
| Kamagra Soft Tabs | 100mg | 84 + 4 Pills | 233.05€ 221.95€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Cialis Professional | 20mg | 180 + 4 Pills | 423.11€ 402.96€ | |
| Cialis Generic | 2.5mg | 270 + 10 Pills | 199.64€ 190.13€ | |
| Kamagra Gold | 100 mg | 12 Pills | 55.64€ 52.99€ | |
| Cialis Black | 80mg | 10 Pills | 43.27€ 41.21€ | |
| Kamagra 100 mg | 100 mg | 12 Pills | 55.64€ 52.99€ | |
| Kamagra Oral Jelly | 100mg | 110 + 9 Sachets | 334.87€ 318.92€ | |
| Cialis Super Active | 20mg | 20 + 4 Pills | 92.35€ 87.95€ | |
| Cialis Original | 20mg | 12 Pills | 78.32€ 74.59€ | |
| Cialis Professional | 20mg | 30 Pills | 104.57€ 99.59€ |
Talk to your care team about the use of this medication in children. It is not approved for use in children. Overdosage: If you think you have taken too much premature ejaculation pills of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others. If you miss your dose at bedtime, skip the missed dose and take the next dose at bedtime the next day. Do not take this medication the next morning or double your next dose. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use.
| Country | Approval Status | Year |
|---|---|---|
| United States | Approved | 2015 |
| Canada | Approved | 2016 |
| European Union | Pending/Under review | N/A |
| Australia | Not approved | N/A |
Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine. Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better after you have taken this medication for 8 weeks. Do not drive, use machinery, or do anything that needs mental alertness for at least 6 hours after your dose and until you know how this medication affects you. Do not stand up or sit up quickly. This reduces the risk of dizzy or fainting spells. Alcohol can increase dizziness and drowsiness, and can increase the risk of low blood pressure or fainting spells when combined with this medication. Wait at least 2 hours after consuming 1 or 2 standard alcoholic drinks before taking this medication at bedtime. Do not take this medication at bedtime if you have consumed 3 or more standard alcoholic drinks that evening.
In case of emergency/overdose
It increases sexual desire and reduces related distress. Take it by mouth, as directed, and avoid grapefruit juice. Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Side effects that you should report to your care team as soon as possible: Allergic reactions or angioedema—skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing CNS depression—slow or shallow breathing, shortness of breath, feeling faint, dizziness, confusion, trouble staying awake Low blood pressure—dizziness, feeling faint or lightheaded, blurry vision Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): This list may not describe all possible side effects. You may report side effects to FDA at 1-800-FDA-1088.
Peds Dosing .
Hypersensitivity Reactions: Reactions including anaphylaxis, reactions consistent with angioedema, pruritus, and urticaria have been reported with ADDYI. Immediately discontinue ADDYI and initiate appropriate treatment if hypersensitivity reaction occurs. Oral Contraceptives and Other Weak CYP3A4 Inhibitors: Increases flibanserin exposures and incidence of adverse reactions. Strong CYP2C19 Inhibitors: Increases super tadapox 100mg flibanserin exposure which may increase risk of hypotension, syncope, and CNS depression. CYP3A4 Inducers: Use of ADDYI not recommended, flibanserin concentrations substantially reduced Digoxin: Increases digoxin concentrations, which may lead to digoxin toxicity.
Label Warnings
Most common adverse reactions (ADDYI incidence ≥2% and higher than placebo) are dizziness, somnolence, nausea, fatigue, insomnia, and dry mouth. See Full Prescribing Information and Medication Guide, including Boxed Warning regarding hypotension and syncope in certain settings. Acquired HSDD refers to HSDD that develops in a patient who previously had no problem with sexual desire. ADDYI is not indicated for use in men. Flibanserin is a medication that treats hypoactive sexual desire disorder, which causes low libido or a lack of sexual desire. Keep out of the reach of children and pets.
| Property | Description | Status |
|---|---|---|
| Approved Uses | Hypoactive Sexual Desire Disorder (HSDD) in women | Yes |
| Mechanism of Action | Serotonin receptor modulator | Partial agonist & antagonist |
| FDA Approval Year | 2015 | |
| Common Brand Name | Addyi |
Store at 25 degrees C (77 degrees F). Get rid of any unused medication after the expiration date.
- The chemical name is 1,2,3,4-tetrahydro-1-{[2-(1,2,3,4-tetrahydro-8-quinolyl)ethyl]amino}methyl-6-fluorobenz[cd]indol-5(6H)-one.
- Molecular formula is C₂₀H₂₁F₃N₄O.
- It is a white to off-white powder that is slightly soluble in water.
- The tablet contains inactive ingredients: microcrystalline cellulose, croscarmellose sodium.
- Also contains magnesium stearate, hypromellose, titanium dioxide, and iron oxide red.
- Manufactured under strict Good Manufacturing Practice (GMP) standards.
- Distributed in bottles or blister packs, typically containing 30 tablets.
- National Drug Code (NDC) for Addyi 100 mg is 0187-XXXX-XX (varies by pack).
- Keep out of reach of children and pets.
To get rid of medications that are no longer needed or have expired: Take the medication to a medication take-back program.
| Interaction Partner | Effect | Advice |
|---|---|---|
| Alcohol | Increased sedation and hypotension | Avoid concurrent use |
| CYP3A4 inhibitors | Elevated flibanserin levels | Dose adjustment or avoid |
| Other serotonergic agents | Increased risk of serotonin syndrome | Avoid concomitant use |
Check with your pharmacy or law enforcement to find a location.
- Reporting of adverse events is encouraged through the FDA MedWatch program.
- Healthcare providers should report syncope, severe hypotension, or liver injury.
- Post-marketing surveillance is critical for understanding rare, long-term risks.
- Drug utilization reviews track prescribing patterns and potential misuse.
- In case of suspected pregnancy, patients should contact their doctor immediately.
- Animal studies showed developmental toxicity at doses much higher than human dose.
- Lactation studies in animals showed excretion in milk; human data are lacking.
- Decision to breastfeed while on flibanserin requires weighing potential risks.
- The benefit for an individual patient must justify the potential risk to a fetus/infant.
If you cannot return the medication, check the label or package insert to see if the medication should be thrown out in the garbage or flushed down the toilet. If you are not sure, ask your care team. If it is safe to put it in the trash, take the medication out of the container. Mix the medication with cat litter, dirt, coffee grounds, or other unwanted substance.
- Flibanserin, a serotonin receptor modulator, was initially investigated for depression.
- Its approval marked a historic moment in treating female sexual dysfunction.
- The medication's side effects necessitate careful patient education.
- Efficacy is often supported by patient-reported improvements in desire.
- It does not function as an aphrodisiac but affects brain chemistry.
- Flibanserin therapy requires adherence to dosing instructions.
- Women with low libido due to other health issues may not benefit from it.
- Its role is to complement behavioral or psychological therapy if needed.
- Research continues into better options for treating female hypoactive sexual desire.
Seal the mixture in a bag or container. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.
Safety and efficacy
Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study. Neural basis of hypoactive sexual desire disorder in women: an event-related fmri study. Holstege G. How the emotional motor system controls the pelvic organs. Attitudinal survey of women living with low sexual desire.
Approval process and advocacy
Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from a randomized withdrawal trial. Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM; SUNFLOWER study investigators. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder. Effect of flibanserin treatment on body weight in premenopausal and postmenopausal women with hypoactive sexual desire disorder: A post hoc analysis. WARNING: HYPOTENSION AND SYNCOPE IN CERTAIN SETTINGS See full prescribing information for complete boxed warning.
How is Addyi supplied (dosage forms)?
Use of ADDYI and alcohol together close in time increases the risk of severe hypotension and syncope. Counsel patients to wait at least two hours after consuming one or two standard alcoholic drinks before taking ADDYI at bedtime or to skip their ADDYI dose if they have consumed three or more standard alcoholic drinks that evening. Severe hypotension and syncope can occur when ADDYI is used with moderate or strong CYP3A4 inhibitors or in patients with hepatic impairment; therefore, ADDYI use in these settings is contraindicated. INDICATION ADDYI (flibanserin) is indicated for the treatment of women less than 65 years of age with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to: A co-existing medical or psychiatric condition, The effects of a medication or other drug substance. Acquired HSDD refers to HSDD that develops in a patient who previously had no problems with sexual desire. Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more. Note: Introduction and Additional Common Questions written and medically approved by Cleveland Clinic professionals. In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin).